Benzinga's Top Upgrades, Downgrades For July 1, 2020

Loading...
Loading...

Upgrades

  • SunTrust Robinson Humphrey upgraded the stock for Cogent Communications Holdings Inc CCOI from Hold to Buy. In the first quarter, Cogent Comms Hldgs showed an EPS of $0.20, compared to $0.20 from the year-ago quarter. The stock has a 52-week-high of $92.96 and a 52-week-low of $53.24. Cogent Comms Hldgs's stock last closed at $77.36 per share.
  • B of A Securities changed the rating for Charles River Laboratories International Inc CRL from Neutral to Buy. Charles River earned $1.84 in the first quarter, compared to $1.40 in the year-ago quarter. The stock has a 52-week-high of $189.85 and a 52-week-low of $95.58. Charles River's stock last closed at $174.22 per share.
  • Rosenblatt upgraded the stock for Square Inc SQ from Neutral to Buy. In the first quarter, Square showed an EPS of ($0.02), compared to $0.11 from the year-ago quarter. The stock has a 52-week-high of $107.84 and a 52-week-low of $32.33. Square's stock last closed at $104.85 per share.
  • Deutsche Bank upgraded the stock for Caterpillar Inc CAT from Hold to Buy. In the first quarter, Caterpillar showed an EPS of $1.60, compared to $2.94 from the year-ago quarter. The stock has a 52-week-high of $150.55 and a 52-week-low of $87.50. Caterpillar's stock last closed at $126.44 per share.
  • Bernstein upgraded the stock for Comcast Corp CMCSA from Market Perform to Outperform. In the first quarter, Comcast showed an EPS of $0.71, compared to $0.76 from the year-ago quarter. The stock has a 52-week-high of $47.74 and a 52-week-low of $31.70. Comcast's stock last closed at $38.98 per share.
  • Goldman Sachs changed the rating for Global Blood Therapeutics Inc GBT from Neutral to Buy. For the first quarter, Global Blood Therapeutics had an EPS of ($1.20), compared to year-ago quarter EPS of ($0.87). The stock has a 52-week-high of $87.54 and a 52-week-low of $39.95. Global Blood Therapeutics's stock last closed at $63.13 per share.
  • For SailPoint Technologies Holdings Inc SAIL, Goldman Sachs upgraded the stock from Sell to Buy. SailPoint Technologies earned $0.04 in the first quarter, compared to $0.00 in the year-ago quarter. The stock has a 52-week-high of $28.00 and a 52-week-low of $11.61. SailPoint Technologies's stock last closed at $26.51 per share.
  • For Spire Inc SR, JP Morgan upgraded the stock from Underweight to Neutral. In the second quarter, Spire showed an EPS of $2.75, compared to $2.90 from the year-ago quarter. The stock has a 52-week-high of $88.00 and a 52-week-low of $57.37. Spire's stock last closed at $65.80 per share.
  • JP Morgan upgraded the stock for FedEx Corp FDX from Neutral to Overweight. FedEx earned $2.53 in the fourth quarter, compared to $5.01 in the year-ago quarter. The stock has a 52-week-high of $178.50 and a 52-week-low of $88.69. FedEx's stock last closed at $140.10 per share.

 

Downgrades

  • For Texas Roadhouse Inc TXRH, Gordon Haskett downgraded the stock from Buy to Hold. Texas Roadhouse earned $0.24 in the first quarter, compared to $0.70 in the year-ago quarter. The stock has a 52-week-high of $72.49 and a 52-week-low of $25.15. Texas Roadhouse's stock last closed at $52.57 per share.
  • Janney Capital changed the rating for Rent-A-Center Inc RCII from Buy to Neutral. For the first quarter, Rent-A-Center had an EPS of $0.67, compared to year-ago quarter EPS of $0.59. The stock has a 52-week-high of $31.14 and a 52-week-low of $11.69. Rent-A-Center's stock last closed at $27.82 per share.
  • Benchmark downgraded the stock for Invitae Corp NVTA from Buy to Hold. For the first quarter, Invitae had an EPS of ($0.80), compared to year-ago quarter EPS of ($0.47). The stock has a 52-week-high of $30.49 and a 52-week-low of $7.42. Invitae's stock last closed at $30.32 per share.
  • Gordon Haskett downgraded the stock for Darden Restaurants Inc DRI from Buy to Hold. Darden Restaurants earned ($1.24) in the fourth quarter, compared to $1.76 in the year-ago quarter. The stock has a 52-week-high of $128.41 and a 52-week-low of $26.15. Darden Restaurants's stock last closed at $75.75 per share.
  • Gordon Haskett changed the rating for Bloomin Brands Inc BLMN from Buy to Hold. Bloomin Brands earned $0.14 in the first quarter, compared to $0.75 in the year-ago quarter. The stock has a 52-week-high of $24.29 and a 52-week-low of $4.54. Bloomin Brands's stock last closed at $10.66 per share.
  • Needham downgraded the stock for Zynerba Pharmaceuticals Inc ZYNE from Buy to Hold. Zynerba Pharmaceuticals earned ($0.53) in the first quarter, compared to ($0.47) in the year-ago quarter. The stock has a 52-week-high of $15.70 and a 52-week-low of $2.55. Zynerba Pharmaceuticals's stock last closed at $3.37 per share.
  • HC Wainwright & Co. changed the rating for Replimune Group Inc REPL from Buy to Neutral. In the fourth quarter, Replimune Group showed an EPS of ($0.41), compared to ($0.15) from the year-ago quarter. The stock has a 52-week-high of $26.22 and a 52-week-low of $8.58. Replimune Group's stock last closed at $24.85 per share.
  • For AGCO Corp AGCO, Deutsche Bank downgraded the stock from Buy to Hold. For the first quarter, AGCO had an EPS of $0.86, compared to year-ago quarter EPS of $0.86. The stock has a 52-week-high of $81.39 and a 52-week-low of $35.33. AGCO's stock last closed at $55.48 per share.
  • For GSX Techedu Inc GSX, Goldman Sachs downgraded the stock from Buy to Neutral. Interestingly, in the first quarter, GSX Techedu's EPS was $0.76. The stock has a 52-week-high of $62.75 and a 52-week-low of $8.83. GSX Techedu's stock last closed at $59.99 per share.
  • JP Morgan changed the rating for South Jersey Industries Inc SJI from Neutral to Underweight. For the first quarter, South Jersey Indus had an EPS of $1.15, compared to year-ago quarter EPS of $1.09. The stock has a 52-week-high of $34.48 and a 52-week-low of $19.62. South Jersey Indus's stock last closed at $25.00 per share.

 

Initiations

  • For Marinus Pharmaceuticals Inc MRNS, Cowen & Co. initiated coverage, by setting the current rating at Outperform. Marinus Pharmaceuticals earned ($0.32) in the first quarter, compared to ($0.24) in the year-ago quarter. The stock has a 52-week-high of $4.83 and a 52-week-low of $0.77. Marinus Pharmaceuticals's stock last closed at $2.54 per share.
  • Benchmark initiated coverage on Halozyme Therapeutics Inc HALO with a Buy rating. The price target for Halozyme Therapeutics is set at $39.00. Halozyme Therapeutics earned ($0.04) in the first quarter, compared to $0.01 in the year-ago quarter. The stock has a 52-week-high of $27.22 and a 52-week-low of $12.71. Halozyme Therapeutics's stock last closed at $26.81 per share.
  • KeyBanc initiated coverage on Coupa Software Inc COUP with an Overweight rating. In the first quarter, Coupa Software showed an EPS of $0.20, compared to $0.03 from the year-ago quarter. The stock has a 52-week-high of $280.15 and a 52-week-low of $99.01. Coupa Software's stock last closed at $277.04 per share.
  • With a rating of Overweight, Stephens & Co. initiated coverage on DraftKings Inc DKNG. The price target is set at $52.00 for DraftKings. DraftKings earned ($0.16) in the first quarter. The stock has a 52-week-high of $44.79 and a 52-week-low of $18.00. DraftKings's stock last closed at $33.26 per share.
  • With a rating of Outperform, Wedbush initiated coverage on Papa John's International Inc PZZA. The price target is set at $95.00 for Papa John's International. Papa John's International earned $0.15 in the first quarter, compared to $0.31 in the year-ago quarter. The stock has a 52-week-high of $85.00 and a 52-week-low of $28.55. Papa John's International's stock last closed at $79.41 per share.
  • JP Morgan initiated coverage on Varonis Systems Inc VRNS with an Overweight rating. The price target for Varonis Systems is set at $130.00. Varonis Systems earned ($0.56) in the first quarter, compared to ($0.38) in the year-ago quarter. The stock has a 52-week-high of $93.33 and a 52-week-low of $48.95. Varonis Systems's stock last closed at $88.48 per share.
  • Stifel initiated coverage on WillScot Corp WSC with a Buy rating. The price target for WillScot is set at $19.00. For the first quarter, WillScot had an EPS of ($0.03), compared to year-ago quarter EPS of ($0.09). The stock has a 52-week-high of $19.79 and a 52-week-low of $7.45. WillScot's stock last closed at $12.29 per share.
  • JP Morgan initiated coverage on Legend Biotech Corp LEGN with an Overweight rating. The price target for Legend Biotech is set at $50.00. The stock has a 52-week-high of $42.88 and a 52-week-low of $35.00. Legend Biotech's stock last closed at $42.56 per share.
  • With a rating of Outperform, SVB Leerink initiated coverage on UnitedHealth Group Inc UNH. The price target is set at $360.00 for UnitedHealth Group. In the first quarter, UnitedHealth Group showed an EPS of $3.72, compared to $3.73 from the year-ago quarter. The stock has a 52-week-high of $315.84 and a 52-week-low of $187.72. UnitedHealth Group's stock last closed at $294.79 per share.
  • With a rating of Outperform, SVB Leerink initiated coverage on Humana Inc HUM. The price target is set at $465.00 for Humana. Humana earned $5.40 in the first quarter, compared to $4.48 in the year-ago quarter. The stock has a 52-week-high of $412.70 and a 52-week-low of $208.25. Humana's stock last closed at $388.21 per share.
  • With a rating of Market Perform, SVB Leerink initiated coverage on CVS Health Corp CVS. The price target is set at $72.00 for CVS Health. CVS Health earned $1.91 in the first quarter, compared to $1.62 in the year-ago quarter. The stock has a 52-week-high of $77.03 and a 52-week-low of $52.04. CVS Health's stock last closed at $64.95 per share.
  • With a rating of Outperform, SVB Leerink initiated coverage on Centene Corp CNC. The price target is set at $78.00 for Centene. Centene earned $0.86 in the first quarter, compared to $1.39 in the year-ago quarter. The stock has a 52-week-high of $74.70 and a 52-week-low of $41.62. Centene's stock last closed at $63.48 per share.
  • With a rating of Market Perform, SVB Leerink initiated coverage on Cigna Corp CI. The price target is set at $220.00 for Cigna. In the first quarter, Cigna showed an EPS of $4.69, compared to $3.90 from the year-ago quarter. The stock has a 52-week-high of $224.64 and a 52-week-low of $118.50. Cigna's stock last closed at $187.71 per share.
  • SVB Leerink initiated coverage on Anthem Inc ANTM with an Outperform rating. The price target for Anthem is set at $325.00. In the first quarter, Anthem showed an EPS of $6.48, compared to $6.03 from the year-ago quarter. The stock has a 52-week-high of $312.48 and a 52-week-low of $171.03. Anthem's stock last closed at $262.99 per share.
Loading...
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Penny StocksUpgradesDowngradesInitiationIntraday UpdateAnalyst RatingsInitiationstop upgrades
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...